Ravicti 1.1 g/ml oral liquid
- Name:
Ravicti 1.1 g/ml oral liquid
- Company:
Immedica Pharma AB
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 07/01/20
(Click to Download) Summary of Product Characteristics last updated on medicines.ie: 7/1/2020
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. Click on this link to Download PDF directly
Immedica Pharma AB
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name Ammonaps 500 mg tablets | Active Ingredients Sodium Phenylbutyrate |
| Medicine Name Ammonaps 940 mg/g granules | Active Ingredients Sodium Phenylbutyrate |
| Medicine Name Ravicti 1.1 g/ml oral liquid | Active Ingredients Glycerol phenylbutyrate |
Items Per Page :
1 - 0 of 3 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 7 January 2020 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 7 January 2020 PIL
Reasons for updating
- New PIL for new product